NZ Pharmaceuticals seeks alternative bile supply 28 Sep 2016
Related articles
- Sick leave expected to increase during World Cup Sport
- Snow on The Remarkables Living
- Budget provides $321m for RS&T activities News
- Government Widens Drought Assistance News
- Positive indicators in labour market Recruitment
- New Zealand food prices fall in February Business
- NZ dairy herd now matches human population Business
Wednesday 28 September 2016 01:19 PM
NZ Pharmaceuticals turns defence into offence for alternative bile supply
By Fiona Rotherham
Sept. 28 (BusinessDesk) - New Zealand Pharmaceuticals, the specialty biopharmaceuticals manufacturer, is researching ways to use alternative raw materials in the manufacture of new products due to a potential shortage of bile supply from cows.
The 45-year-old company was originally set up by a consortium of New Zealand meat companies to extract and purify biochemicals from meat processing by-products. Its first products were pharmaceutical intermediaries for the global healthcare market, extracted from cow and sheep bile.
The Manawatu-based company is best known for making high purity bile acids, which comprise the majority of turnover. It’s the world’s second-largest manufacturer of cholic acid, which is used in a range of pharmaceutical and diagnostic applications such as treatments for liver disease.
After Andy Lewis took over the chief executive role in 2010 he decided the company, which now has 150 staff in New Zealand and the UK, had got too diversified and needed to “defend on bile acids”. His strategy involves developing new bile acids which are used in modern western medicines and traditional Chinese (Eastern) medicines.
An NZP business development scientist spent two years travelling the world talking to drug companies and research groups to identify bile acids being evaluated for new therapeutic uses as varied as oncology, neurodegenerative and metabolic disorders including type 2 diabetes and obesity. In one published example, researchers at Penn State have found a bile acid that can turn off a receptor in the gut which has prevented and reversed fatty liver disease in mice and could help treat certain metabolic disorders such as type 2 diabetes and obesity.
Earlier this month, Lewis told the NZBio annual conference in Auckland that future growth opportunities involving bile acids appear “very positive” and the company has invested heavily during the past decade in its infrastructure and regulatory systems to underpin its growth aspirations. In 2009, the company also acquired UK-based R&D company, Dextra Laboratories, which specialises in a range of carbohydrates and blood group products, in order to undertake a more extensive bile acids R&D programme.
“We decided to stop trying to develop products in new fields and specialise on the product group for which we have become identified, and we believe this is a good strategy for other small to medium sized New Zealand companies trying to foot it on the global stage,” he said.
NZP’s market share for bile acids has gone from 25 to 35 percent in the past eight years and profits have been ploughed back into improving infrastructure and R&D.
“That’s always challenging when you have investors,” he said.
NZP got a $49.6 million injection earlier this year from its new controlling shareholder, Archer Capital, to help expand research and development into new products. The Australian private equity firm has a 73 percent stake with the rest held by current and former management staff.
One of the key problems NZP faced with a potential upsurge in demand for bile acids was a “looming tsunami” in terms of its global supply chain of bovine (cow) bile. It identified around 200 million cows worldwide from which it could collect the liquid bile and bring into the country under New Zealand’s strict biosecurity laws and figured it had about nine years at current and projected growth rates to solve the supply conundrum.
It currently collects around 60 million cows’ worth of cow bile and has worked with the Ministry for Primary Industries to increase the number of countries it can import from, which have to have no disease and vets in the abattoirs, from 27 to 72. It also added 70 countries it could collect sheep bile from because it’s chemically identical to that of cows. There are around one billion sheep and goats worldwide “so we’re really as interested in that”, Lewis said.
It also started looking at non-animal alternatives in the “phyto-sterile” or plant space. “We’ve been very successful developing IP in that area and we’re now into scale up and bridging with late stage clinical providers,” he said.
Lewis is not keen on revealing anything about the non-animal alternatives though other sources have indicated sunflower seeds and avocados could be involved.
“We started to turn an ‘oh shit’ moment into what can we do about it,” he said. “The defensive strategy has turned into a positive.”
NZP has confidential supply arrangements in place with some pharmaceutical companies working on the novel bile acid applications and has also done R&D collaborations which are now the subject of patent applications.
While the late-stage clinical drug programmes may bear fruit in the next few years to 2020, NZP’s private capital investors wanted a longer-term strategy in place as well. NZP has been developing its own bile acids using some of the knowledge coming out of the drug research, and trying to find bile acid compounds that target the receptors.
It has developed 472 novel bile acids which had made it through the initial three screenings in the areas of therapy for oncology, neuro degenerative disease and metabolic disease.
“We’ve got six good hits and are now in the hit to lead design phase and working out how on earth a company of our scale can cope with the potential to have several of these and what sort of strategy it really requires,” Lewis said.
(BusinessDesk)
News
Hilary Timmins' Award-Winning UK Documentary Series To Inspire NZ Students
29 Jun 2020 Education
Dream Catchers, produced and directed by Hilary Timmins, celebrates the success stories of more than thirty inspirational New... more
New Zealand reaffirms support for Flight MH17 judicial process
7 Mar 2020 News
Ahead of the start of the criminal trial in the Netherlands on 9 March, Foreign Minister Winston Peters has reaffirmed the need to... more
Business
NZ Government's Economic package to fight COVID-19
17 Mar 2020 Business News
The Coalition Government has launched the most significant peace-time economic plan in modern New Zealand history to cushion the... more
NZ Government announces aviation relief package
19 Mar 2020 Business News
Transport Minister Phil Twyford today outlined the first tranche of the $600 million aviation sector relief package announced earlier... more
Living
Diversity was Key at New Zealand Trade Tasting in London
6 Jun 2022 Food & Wine
New Zealand Winegrowers Annual Trade Tasting was recently held in London, on Wednesday 4 May, in Lindley Hall.
It was the first... more
Kiwi author stuns Behind the Butterfly Gate
12 Jan 2022 Arts
Hidden behind the Butterfly Gate is where the secret has been kept for 76 years...
New Zealand writer Merryn Corcoran’s... more
Property
Fairer rules for tenants and landlords
17 Nov 2019 Property
17 NOVEMBER 2019
The Government has delivered on its promise to the over one million New Zealanders who now rent to make it fairer... more
New Zealand Government will not implement a Capital Gains Tax
17 Apr 2019 Property
The Coalition Government will not proceed with the Tax Working Group’s recommendation for a capital gains tax, Jacinda Ardern... more
Migration
Boosting border security with electronic travel authority – now over 500,000 issued
19 Nov 2019 Migration
19 NOVEMBER 2019
We’ve improved border security with the NZeTA, New Zealand Electronic Travel Authority, which helps us to... more
Christchurch reinstated as refugee settlement location
18 Aug 2018 Migration
18 AUGUST 2018
HON IAIN LEES-GALLOWAY
The announcement that Christchurch can once again be a settlement location for refugees... more
Travel
Gallipoli Anzac Day services cancelled
19 Mar 2020 Travel & Tourism
The New Zealand and Australian Governments have announced this year’s joint Anzac Day services at Gallipoli will be cancelled... more
New Zealanders advised not to travel overseas
19 Mar 2020 Travel & Tourism
New Zealanders advised not to travel overseas
more
Sport
The Skipper's Diary: Sir Richard Hadlee honouring his father and NZ's Forty-Niners
27 Oct 2019 Cricket
NZNewsUK London Editor Charlotte Everett spoke to Sir Richard Hadlee about why he’s chosen to publish his father’s... more
PREVIEW: All Blacks v England semi-final
26 Oct 2019 Rugby
The two most convincing quarterfinals winners are set to square off in a semifinal showdown for the ages when the All Blacks meet old... more
Columns
Gordon Campbell on the Gareth Morgan crusade
11 Nov 2016 Opinion
Gordon Campbell on the Gareth Morgan crusade
First published on Werewolf
The ghastly likes of Marine Le Pen in France and Geert ... more
Gordon Campbell on the US election outcome
10 Nov 2016 Opinion
Column - Gordon Campbell
Gordon Campbell on the US election outcome
Well um.. on the bright side, there (probably)... more
Kiwi Success
Congratulations to Loder Cup winner
26 Sep 2018 People
25 SEPTEMBER 2018
The Loder Cup, one of New Zealand’s oldest conservation awards, has been awarded to Robert McGowan for 2018... more
Appointments to New Zealand National Commission for UNESCO
16 Aug 2018 Appointments
16 AUGUST 2018Appointments to New Zealand National Commission for UNESCO
HON JENNY SALESA
Associate Education Minister Jenny Salesa is... more
Recruitment
Historic pay equity settlement for education support workers
14 Aug 2018 Recruitment
14 AUGUST 2018Historic pay equity settlement for education support workers
RT HON JACINDA ARDERN
HON CHRIS HIPKINS
Prime Minister
The... more
Historic pay equity settlement for education support workers
22 Aug 2018 Recruitment
14 AUGUST 2018Historic pay equity settlement for education support workers
RT HON JACINDA ARDERN
HON CHRIS HIPKINS
Prime Minister
The... more